Q. Sartorius has participated in BIX for 5 consecutive years, from the inaugural BIX 2020 to this year’s BIX 2024. We would like to extend our sincere gratitude for your continued support and participation in BIX! Have you achieved any successful business outcomes or results through your participation in BIX? We would also like to inquire about the background for your continuous participation.

A. BIX attracts key stakeholders from domestic and international markets every year. By consistently participating in BIX, Sartorius has been able to establish strategic partnerships and collaborations, enhancing its position as a leader in the biotechnology field. Going forward, we will continue to prioritize BIX as a significant annual event, focusing on strengthening our brand recognition and credibility. We aim to be a partner for both established and emerging companies in the biotech and pharmaceutical industries.

Q. At BIX 2023, you showcased not only laboratory-related equipment but also process-related equipment, allowing you to meet a diverse range of visitors. What aspects should visitors pay attention to at this year’s Sartorius booth? Are there any key products or technologies you would like to highlight?

A. In addition to laboratory equipment and production process-related devices, Sartorius performs various tests related to the certification of biopharmaceuticals and has research personnel dedicated to cell manufacturing and QA tasks. At the Sartorius booth at BIX 2024, on-site seminars will be held regularly, focusing on the services provided by our research laboratories. If you are interested in learning more about our services such as Filter Validation Service, Virus Clearance Service, and GLP Study Service, please visit the Sartorius Korea booth!

Q. At BIX 2023 business session, you introduced newly launched software. For this year’s business session, you have announced that you will be presenting on the topic ‘Innovative Technologies in Nucleic acid & LNP Research: PATfix HPLC Platform.’ Could you provide some hints on the key points that visitors should not miss during the session, as well as any promotional information?

A. At the BIX 2023 Business Session, Sartorius is pleased to introduce the "Innovative Technologies in Nucleic Acid & LNP Research: PATfix HPLC Platform." Key points not to be missed in this session include the following:

Firstly, it is an All-in-One HPLC that includes all recommended detectors for nucleic acid and LNP analysis, allowing for rapid and accurate analysis of various samples.

Secondly, it provides pre-validated analytical methods and SOPs, enabling researchers to conduct experiments efficiently.

Thirdly, it includes CIMac analytical columns that facilitate quick analysis from the IVT process to the purification process of mRNA.

Fourthly, it offers mRNA standards for System Suitability Testing (SST), ensuring the reliability and consistency of the system.

A real-time demo and Q&A session will also be available, so we look forward to your interest and participation!

Q. Over the past 5 years of participating in BIX, Sartorius’s leadership has contributed to our growth. From Sartorius’s perspective, what are your expectations for BIX 2024 compared to previous years?

A. We understand that around 10,000 visitors attend BIX each year. It would be great if these diverse visitors not only toured the booths but also showed interest in and attended various corporate sessions. As the conference consists of keynote speeches and specialized sessions offering insights into the latest in the biotech industry, it provides a valuable opportunity for visitors to experience the technologies and solutions offered by each company.